Quantification of trace element contents in frozen fluid inclusions by UV-fs-LA-ICP-MS analysis

We have developed a new analytical setup for the determination of trace element concentrations in fluid inclusions by UV-fs-LA-ICP-MS. Laser ablation was performed at a low temperature of -40 degrees C by using a modified heating-freezing stage as the ablation cell. With this method it was possible to successfully analyse 53 of 55 frozen synthetic NaCl-H2O fluid inclusions in quartz, covering a size range between 8 mu m and 25 mu m down to a depth of 50 mu m. The high success rate could be achieved as the 194 nm UV-fs-laser allows excellent control over the opening procedure of frozen fluid inclusions. Trace element analyses were performed with a fast scanning magnetic sector field ICP-MS. The lower limits of detection for fluid inclusion analysis vary from 0.1 mu g g(-1) (for Bi-209) to 10 mu g g(-1) (for K-39). The typical analytical uncertainty, depending on the element and respective concentration level, ranges between 10% and 30% (1RSD), based on the reproducibility of experimentally synthesized fluid inclusions. All elements from a stock solution, which behaved inert during the HP/HT experiments (B, K, Cd, Te, Tl, Pb and Bi), could be recovered in the synthetic inclusions at concentrations that correspond within their specific analytical uncertainties to their original concentration of 53 mu g g(-1). The method represents a highly efficient tool for the determination of accurate trace element data on low concentration levels in small fluid inclusions with a high success rate of >90%. The latter is particularly advantageous considering the commonly time consuming characterization of fluid inclusions.NTH Graduate School GeoFluxe

Experimental tests on achieving equilibrium in synthetic fluid inclusions: Results for scheelite, molybdenite, and gold solubility at 800 °C and 200 MPa

Synthetic fluid inclusions formed in high P-T experiments, which are subsequently analyzed with LA-ICP-MS, enable us to collect thermodynamic data to constrain metal transport in aqueous fluids as well as partitioning of metals between coexisting phases. The most essential prerequisite for such studies is to ensure that equilibrium conditions between liquid and solid phases are reached prior to the formation of synthetic fluid inclusions in the host mineral. Various methods have been proposed by different authors to achieve this goal, but to this point our knowledge on the best approach to synthesize equilibrated fluid inclusions under constrained pressure, temperature, and compositional (P, T, and X) conditions remains poor. In addition, information on the time needed to reach equilibrium metal concentrations in the fluid as well as on the timing of the onset of fluid inclusion formation in the host mineral are scarce. The latter has been tested in a series of time-dependent experiments at 800 °C and 200 MPa using scheelite (CaWO4), molybdenite (MoS2) and metallic gold as dissolving phases and using different approaches to optimize the formation of equilibrated fluid inclusions. Both Embedded Image and Embedded Image were fixed during all experiments using the pyrite-pyrrhotite-magnetite buffer (PPM). As an intermediate in situ quenching of the sample charge plays an important role in the synthesis of fluid inclusions, we further tested the efficiency of such an intermediate quench for re-opening fluid inclusions formed at 600 °C and 200 MPa. Our results reveal that fluid inclusions start forming almost instantaneously and that equilibrium between fluid and solid phases occurs in the timescale of less than two hours for molybdenite and gold up to ca. 10 h for scheelite. The best approach to synthesize equilibrated fluid inclusions at 800 °C was obtained by using an intermediate quench on a previously unfractured quartz host. Experiments at 600 °C showed similar results and illustrate that this should be the method of choice down to this temperature. Below 600 °C pre-treatment of the quartz host (HF etching and/or thermal fracturing) becomes important to produce large enough fluid inclusions for the analyses via LA-ICP-MS and special care must be taken to prevent premature entrapment of the fluid. Fluids with 8 wt% NaCl in equilibrium with scheelite, molybdenite and gold at 800 °C and 200 MPa have concentrations of ca. 7300 ppm W, 1300 ppm Mo, and 300 ppm Au, respectively, which is in good agreement with results from other studies or extrapolation from lower temperatures. It can be concluded that the formation of synthetic fluid inclusions from an equilibrated fluid is possible, but different experimental designs are required, depending on the investigated temperature. In general, dissolution of solid phases seems to be much faster than previously assumed, so that experimental run durations can be designed considerably shorter, which is of great advantage when using fast-consuming mineral buffers.State of Lower SaxonyGraduate School GeoFluxesLeibniz Universität Hannove

Negative affective burden is associated with higher resting-state functional connectivity in subjective cognitive decline

Publisher Copyright: © 2022, The Author(s).Subjective cognitive decline (SCD), as expressed by older adults, is associated with negative affect, which, in turn, is a likely risk factor for Alzheimer’s Disease (AD). This study assessed the associations between negative affective burden, cognitive functioning, and functional connectivity in networks vulnerable to AD in the context of SCD. Older participants (60–90 years) with SCD (n = 51) and healthy controls (n = 50) were investigated in a cross-sectional study. Subclinical negative affective burden, quantified through a composite of self-reported negative affective factors, was related to cognitive functioning (self-perceived and objective) and functional connectivity. Seed-to-voxel analyses were carried out in default mode network (DMN) and salience network (SAL) nodes using resting-state functional magnetic resonance imaging. Greater negative affective burden was associated with lower self-perceived cognitive functioning and lower between-network functional connectivity of DMN and SAL nodes in the total sample. In addition, there was a significant moderation of SCD status. Greater negative affective burden related to higher functional connectivity within DMN (posterior cingulate-to-precuneus) and within SAL (anterior cingulate-to-insula) nodes in the SCD group, whereas in controls the inverse association was found. We show that negative affective burden is associated with functional brain alterations in older adults, regardless of SCD status. Specifically in the SCD phenotype, greater negative affective burden relates to higher functional connectivity within brain networks vulnerable to AD. Our findings imply that negative affective burden should be considered a potentially modifiable target for early intervention.Peer reviewe

Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)—study protocol for a randomized controlled trial

Background: Given the global increase in the aging population and age-related diseases, the promotion of healthy aging is one of the most crucial public health issues. This trial aims to contribute to the establishment of effective approaches to promote cognitive and brain health in older individuals with subjective cognitive decline (SCD). Presence of SCD is known to increase the risk of objective cognitive decline and progression to dementia due to Alzheimer’s disease. Therefore, it is our primary goal to determine whether spermidine supplementation has a positive impact on memory performance in this at-risk group, as compared with placebo. The secondary goal is to examine the effects of spermidine intake on other neuropsychological, behavioral, and physiological parameters. Methods: The SmartAge trial is a monocentric, randomized, double-blind, placebo-controlled phase IIb trial. The study will investigate 12 months of intervention with spermidine-based nutritional supplementation (target intervention) compared with 12months of placebo intake (control intervention). We plan to recruit 100 cognitively normal older individuals with SCD from memory clinics, neurologists and general practitioners in private practice, and the general population. Participants will be allocated to one of the two study arms using blockwise randomization stratified by age and sex with a 1:1 allocation ratio. The primary outcome is the change in memory performance between baseline and post-intervention visits (12 months after baseline). Secondary outcomes include the change in memory performance from baseline to follow-up assessment (18months after baseline), as well as changes in neurocognitive, behavioral, and physiological parameters (including blood and neuroimaging biomarkers), assessed at baseline and post-intervention. Discussion: The SmartAge trial aims to provide evidence of the impact of spermidine supplementation on memory performance in older individuals with SCD. In addition, we will identify possible neurophysiological mechanisms of action underlying the anticipated cognitive benefits. Overall, this trial will contribute to the establishment of nutrition intervention in the prevention of Alzheimer’s disease

Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium

Post-cardiac arrest myocardial dysfunction is a common phenomenon after return of spontaneous circulation (ROSC) and contributes to hemodynamic instability and low survival rates after cardiac arrest. Mild hypothermia for 24 h after ROSC has been shown to significantly improve neurologic recovery and survival rates. In the present study we investigate the influence of therapeutic hypothermia on hemodynamic parameters in resuscitated patients and on contractility in failing human myocardium. We analyzed hemodynamic data from 200 cardiac arrest survivors during the hypothermia period. The initial LVEF was 32.6 ± 1.2% indicating a significantly impaired LV function. During hypothermia induction, the infusion rate of epinephrine could be significantly reduced from 9.1 ± 1.3 μg/min [arrival intensive care unit (ICU) 35.4°C] to 4.6 ± 1.0 μg/min (34°C) and 2.8 ± 0.5 μg/min (33°C). The dobutamine and norepinephrine application rates were not changed significantly. The mean arterial blood pressure remained stable. The mean heart rate significantly decreased from 91.8 ± 1.7 bpm (arrival ICU) to 77.3 ± 1.5 bpm (34°C) and 70.3 ± 1.4 bpm (33°C). In vitro we investigated the effect of hypothermia on isolated ventricular muscle strips from explanted failing human hearts. With decreasing temperature, the contractility increased to a maximum of 168 ± 23% at 27°C (n = 16, P < 0.05). Positive inotropic response to hypothermia was accompanied by moderately increased rapid cooling contractures as a measure of sarcoplasmic reticulum (SR) Ca2+ content, but can be elicited even when the SR Ca2+ release is blocked in the presence of ryanodine. Contraction and relaxation kinetics are prolonged with hypothermia, indicating increased Ca2+ sensitivity as the main mechanism responsible for inotropy. In conclusion, mild hypothermia stabilizes hemodynamics in cardiac arrest survivors which might contribute to improved survival rates in these patients. Mechanistically, we demonstrate that hypothermia improves contractility in failing human myocardium most likely by increasing Ca2+-sensitivity

A system theory based digital model for predicting the cumulative fluid balance course in intensive care patients

Background: Surgical interventions can cause severe fluid imbalances in patients undergoing cardiac surgery, affecting length of hospital stay and survival. Therefore, appropriate management of daily fluid goals is a key element of postoperative intensive care in these patients. Because fluid balance is influenced by a complex interplay of patient-, surgery- and intensive care unit (ICU)-specific factors, fluid prediction is difficult and often inaccurate.Methods: A novel system theory based digital model for cumulative fluid balance (CFB) prediction is presented using recorded patient fluid data as the sole parameter source by applying the concept of a transfer function. Using a retrospective dataset of n = 618 cardiac intensive care patients, patient-individual models were created and evaluated. RMSE analyses and error calculations were performed for reasonable combinations of model estimation periods and clinically relevant prediction horizons for CFB.Results: Our models have shown that a clinically relevant time horizon for CFB prediction with the combination of 48 h estimation time and 8–16 h prediction time achieves high accuracy. With an 8-h prediction time, nearly 50% of CFB predictions are within ±0.5 L, and 77% are still within the clinically acceptable range of ±1.0 L.Conclusion: Our study has provided a promising proof of principle and may form the basis for further efforts in the development of computational models for fluid prediction that do not require large datasets for training and validation, as is the case with machine learning or AI-based models. The adaptive transfer function approach allows estimation of CFB course on a dynamically changing patient fluid balance system by simulating the response to the current fluid management regime, providing a useful digital tool for clinicians in daily intensive care

Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline : Decline A Randomized Clinical Trial

IMPORTANCE Developing interventions against age-related memory decline and for older adults experiencing neurodegenerative disease is one of the greatest challenges of our generation. Spermidine supplementation has shown beneficial effects on brain and cognitive health in animal models, and there has been preliminary evidence of memory improvement in individuals with subjective cognitive decline. OBJECTIVE To determine the effect of longer-term spermidine supplementation on memory performance and biomarkers in this at-risk group. DESIGN, SETTING, AND PARTICIPANTS This 12-month randomized, double-masked, placebocontrolled phase 2b trial (the SmartAge trial) was conducted between January 2017 and May 2020. The study was a monocenter trial carried out at an academic clinical research center in Germany. Eligible individuals were aged 60 to 90 years with subjective cognitive decline who were recruited from health care facilities as well as through advertisements in the general population. Data analysis was conducted between January and March 2021. INTERVENTIONS One hundred participants were randomly assigned (1:1 ratio) to 12 months of dietary supplementation with either a spermidine-rich dietary supplement extracted from wheat germ (O.9 mg spermidine/d) or placebo (microcrystalline cellulose). Eighty-nine participants (89%) successfully completed the trial intervention. MAIN OUTCOMES AND MEASURES Primary outcome was change in memory performance from baseline to 12-month postintervention assessment (intention-to-treat analysis), operationalized by mnemonic discrimination performance assessed by the Mnemonic Similarity Task. Secondary outcomes included additional neuropsychological, behavioral, and physiological parameters. Safety was assessed in all participants and exploratory per-protocol, as well as subgroup, analyses were performed. RESULTS A total of 100 participants (51 in the spermidine group and 49 in the placebo group) were included in the analysis (mean [SD] age, 69 [5] years; 49 female participants [49%]). Over 12 months, no significant changes were observed in mnemonic discrimination performance (between-group difference, -0.03; 95% CI, -0.11 to 0.05; P = .47) and secondary outcomes. Exploratory analyses indicated possible beneficial effects of the intervention on inflammation and verbal memory. Adverse events were balanced between groups. CONCLUSIONS AND RELEVANCE In this randomized clinical trial, longer-term spermidine supplementation in participants with subjective cognitive decline did not modify memory and biomarkers compared with placebo. Exploratory analyses indicated possible beneficial effects on verbal memory and inflammation that need to be validated in future studies at higher dosage.Peer reviewe